BioLife Solutions (BLFS) Tops Q4 EPS by 4c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts BLFS Hot Sheet
Price: $38.61 --0%
Revenue Growth %: +3.9%
Financial Fact:
Operating loss: -1.14M
Today's EPS Names:
ATS, SICP, FTCO, More
Revenue Growth %: +3.9%
Financial Fact:
Operating loss: -1.14M
Today's EPS Names:
ATS, SICP, FTCO, More
Join SI Premium – FREE
BioLife Solutions (NASDAQ: BLFS) reported Q4 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $32.7 million versus the consensus estimate of $33.4 million.
GUIDANCE:
BioLife Solutions sees FY2024 revenue of $95.5-100 million, versus the consensus of $106.3 million.
For earnings history and earnings-related data on BioLife Solutions (BLFS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- a.k.a. Brands Holding Corp. (AKA) Misses Q3 EPS by 37c; Offers Guidance
- Cytokinetics (CYTK) Tops Q3 EPS by 8c, Beats on Revenue
- LegalZoom (LZ) Misses Q3 EPS by 1c; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
